TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The CDC’s updated 2026 Antimicrobial Resistance Threats Report lists 19 pathogens, including four drug-resistant organisms rated urgent threats. The agency estimates the pathogens together cause 9.7 million infections and 50,800 deaths annually in the United States; the report also moves C. difficile to the serious category and adds six organisms to a watch list.
The CDC’s updated 2026 Antimicrobial Resistance Threats Report identifies 19 pathogens as concerning, serious or urgent threats and estimates that they collectively cause 9.7 million infections and 50,800 deaths in the United States each year. Four drug-resistant pathogens—Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales and drug-resistant Neisseria gonorrhoeae—are in the report’s top-tier urgent category.
The agency also placed six pathogens on a watch list because they could become public health threats, though their disease burden is uncertain. Additions include drug-resistant dermatophytes, drug-resistant Haemophilus influenzae and nontuberculous mycobacteria. Drug-resistant Neisseria meningitidis was classified as a serious threat requiring prompt, sustained action.
The report says Clostridioides difficile moved down from urgent to serious. The CDC attributed the shift in part to infection-prevention measures that have reduced cases since 2011. That change is a category reassessment; it does not mean the pathogen is no longer a concern.
The report’s figures cover the pathogens collectively, rather than the four urgent threats alone. For some individual organisms, it gives 2023 estimates: carbapenem-resistant Acinetobacter was associated with 9,497 U.S. hospitalizations and 817 deaths, while carbapenem-resistant Enterobacterales was associated with 14,878 hospitalizations and 1,252 deaths. Drug-resistant gonorrhea caused an estimated 787,000 U.S. infections that year.
Risks to Treatment and Hospital Care
Antimicrobial resistance can make infections harder to treat when medicines that would normally work are less effective. The impact reaches beyond the infection itself: drug-resistant infections can extend hospital stays and limit treatment options, especially for patients who are already medically vulnerable or require invasive care.
Wendy Armstrong, president of the Infectious Diseases Society of America, said resistant infections can make it difficult or sometimes impossible for clinicians to safely provide care such as cancer chemotherapy, organ transplants and surgery. That is an assessment from the medical society’s president, not a finding that every resistant infection prevents those treatments.
The report also has implications for prevention and drug development. The CDC’s separate watch list signals areas where more attention may be needed, while its threat rankings can help focus public health and research efforts. The available report summary does not set out a specific response timetable for each pathogen.
Products Worth Considering
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Hyperice Normatec 3 Leg Compression Boots, Standard Size
Bowflex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
How the CDC Reassessed Pathogens
The updated report groups pathogens by assessed threat level, with categories ranging from concerning and serious to urgent, and includes a watch list for potential threats with uncertain disease burdens. This structure distinguishes organisms already assessed as major public health threats from those the agency is monitoring for possible growth in risk.
The individual figures in the report refer to different measures and years. For example, the CDC reported that U.S. C. auris cases rose from 48 in 2016 to 4,523 in 2023. For carbapenem-resistant Acinetobacter, most reported 2023 cases began outside hospitals, according to the supplied report summary. The figures should not be read as a single-year count of deaths from all resistant infections.
Armstrong also called for passage of the PASTEUR Act, which she said would establish a federal program to support development of antimicrobial drugs targeting threatening pathogens and infections. The source report says versions of the bill remain stalled in congressional committees.
“These numbers are alarming by any measure, but they are particularly sobering when infectious diseases physicians connect real patients with these statistics in their everyday experience.”
— Wendy Armstrong, president of the Infectious Diseases Society of America
Limits of the Threat Estimates
The report summary provides a combined annual estimate of 9.7 million infections and 50,800 deaths, but does not break those totals down by pathogen in the information supplied. It is therefore unclear from these figures how much each organism contributes to the overall burden, or how the combined estimate was calculated.
Some watch-list pathogens have an uncertain disease burden, and their placement signals potential concern rather than a confirmed estimate of future cases. The summary also does not provide full methods, detailed year-to-year comparisons for every organism, or a complete account of what changes drove each classification.
Drug Development and Public Health Response
Public health agencies and health-care systems will need to use the threat rankings alongside surveillance and infection-prevention work. The supplied report summary does not specify new implementation deadlines or particular measures for each pathogen, so the immediate operational response remains unclear.
Armstrong urged lawmakers to advance the PASTEUR Act, but the bill’s congressional progress is uncertain: the source says both versions remain in committee. Further details on the report’s methods, pathogen-specific burden estimates and any agency response plans would help clarify how the rankings will shape policy and care.
Key Questions
How many infections and deaths does the CDC estimate?
The CDC estimates that the pathogens covered by its 2026 report collectively cause 9.7 million infections and 50,800 deaths annually in the United States. The supplied summary does not allocate those totals among individual pathogens.
Which pathogens are rated urgent threats?
The four named urgent threats are Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales and drug-resistant Neisseria gonorrhoeae.
Does C. difficile remain a threat?
Yes. The CDC moved C. difficile from urgent to serious, citing infection-prevention measures that have helped reduce cases since 2011. The lower category does not mean the infection is no longer a concern.
What does the CDC watch list mean?
The watch list includes pathogens the CDC considers potential threats whose disease burden may be uncertain. Their inclusion is a monitoring signal, not proof that they will cause a particular number of infections or deaths.
What is the status of the PASTEUR Act?
Armstrong called for the bill, which she said would create a federal program to support development of antimicrobial drugs. The source report says both versions remain stalled in congressional committees.
Source: medpagetoday.com
